Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
about
The role of tumor microenvironment in therapeutic resistanceTargeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosisPathogenesis of Systemic Sclerosis.Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.Endothelial Dysfunction and Mechanobiology in Pathological Cutaneous Scarring: Lessons Learned from Soft Tissue Fibrosis.Pathogenesis of systemic sclerosis-current concept and emerging treatments.Impaired angiogenesis as a feature of digital ulcers in systemic sclerosis.Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors.Wenyang Huazhuo Tongluo formula inhibits fibrosis via suppressing Wnt/β-catenin signaling pathway in a Bleomycin-induced systemic sclerosis mouse model.Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin
P2860
Q28069049-BFCCB5E4-FCD5-428F-864F-92A4C08BA7D2Q33603627-BBCAEC13-D0B0-4880-A819-867E808BF8A8Q33795658-F158D399-E42D-4E2B-A834-2DFA5A779B1BQ35693212-1697B30B-E3A3-4EF3-820F-4111FAB9A5AFQ37224668-94B5A29F-BB84-4911-87B1-721DA004D0E6Q39238174-F135A4F3-1B88-4232-83C9-0836DF10F7F2Q39294794-6FCBE31C-FFBF-44C4-98BA-620EC088F8BDQ40355666-D4A11CA6-EBF6-4FF5-907A-B7C38001BB5DQ45803566-A8B770ED-B53A-488B-8568-C6164CCC588EQ54093499-42ECAE24-EDA7-4B17-A9A4-3ABB0020E902Q57486499-FA57A4F2-C636-4DD3-888F-9F8C75440FDC
P2860
Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Systemic sclerosis endothelial ...... mal-to-mesenchymal transition.
@en
Systemic sclerosis endothelial ...... onnective tissue growth factor
@nl
type
label
Systemic sclerosis endothelial ...... mal-to-mesenchymal transition.
@en
Systemic sclerosis endothelial ...... onnective tissue growth factor
@nl
prefLabel
Systemic sclerosis endothelial ...... mal-to-mesenchymal transition.
@en
Systemic sclerosis endothelial ...... onnective tissue growth factor
@nl
P2093
P2860
P50
P356
P1476
Systemic sclerosis endothelial ...... mal-to-mesenchymal transition.
@en
P2093
Anastasia Chillà
Anna Laurenzana
Bashar Kahaleh
Esperanza Feijoo
Francesca Margheri
Javier Dotor
Laura Bazzichi
Paola Chiarugi
Simona Serratì
P2860
P304
P356
10.1002/ART.37705
P577
2013-01-01T00:00:00Z